Chronic Kidney Disease

Life Science News

Rectify Pharma and Boehringer Ink $448M Deal to Advance CKD Pipeline
Biotech News

“It Takes 2” with Boehringer Ingelheim and Eli Lilly as They Spotlight Kidney Health
Biotech Blogs

Redefining Autoimmune Kidney Disease Treatment Through Science-Led Innovation
Biotech Blogs

World Lupus Day 2025: Emerging Pipeline Advances from Biopharma
Approvals News

Vanrafia (Atrasentan) Earns FDA Approval for IgAN, Achieved Proteinuria Reduction
Life Science Podcast

Targeting Pressing Unmet Needs in Kidney Diseases with Unicycive Therapeutics CEO Dr. Shalabh Gupta — Episode 201
Approvals News

Novartis’ Fabhalta (Iptacopan) Earns Third FDA Nod, This Time for C3G
Biotech Blogs

Taking Charge on National Kidney Month 2025 and World Kidney Day 2025: Are Your Kidneys OK?
Life Science Podcast

Biotech Disruptors: Rectify Phama’s Dr. Raj Devraj on Transforming Early Clinical Development — Xtalks Life Science Podcast Ep. 198
Biotech News

Maze Therapeutics Introduces IPO with Two CKD Candidates in Clinical Trials
Approvals News

FDA Approves New Use for Ozempic to Reduce the Risks of Kidney Disease
Clinical Trial News

Cenerimod Reduces SLE Disease Activity, Paves the Way for Phase III
Biotech News

Sibeprenlimab Reduces Proteinuria in Phase III IgA Nephropathy Trial
Blogs

The National Kidney Foundation’s Role in Advancing Clinical Trials in Nephrology
Life Science Podcast

Cell Therapies for Chronic Kidney Disease: Featuring Bruce Culleton, CEO, ProKidney – Xtalks Life Science Podcast Ep. 153
Blogs

Tackling Diabetic Kidney Disease: Featuring Robert Perkins, VP, US Medical Affairs (Renal), Bayer – Xtalks Life Science Podcast Ep. 152